University of Maryland School of Medicine surgeons have identified a group of lymph nodes in the chest that appear highly significant in predicting the prognosis for patients with malignant pleural mesothelioma.
Pfizer Inc. and Astellas Pharma Inc. announced results from the phase III ARCHES trial in men with metastatic hormone-sensitive prostate cancer.
Bristol-Myers Squibb Co. announced new results from the phase III CheckMate-214 study, showing that therapy with Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) continued to demonstrate long-term survival benefits in patients with previously untreated advanced or metastatic renal cell carcinoma.
A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before surgery could help prolong their lives.
The black-white gap has closed considerably over the past several decades, a new report finds.
The American Cancer Society Cancer Action Network released a report that report examines the growing burden of cervical cancer in low- and middle-income countries around the world.
Researchers at Georgetown Lombardi Comprehensive Cancer Center released a study that may show immunotherapy offers similar benefit to cancer patients living with HIV.
The first report from a phase II, multi-center clinical trial indicates that a newer, more aggressive form of radiation therapy, stereotactic radiation, can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life.
Noxopharm announced interim results from the dose-ranging component of the DARRT-1 study. Some of their key findings include combining Veyonda with low-dose radiotherapy applied to a single metastasis is able to produce an anti-cancer response in both the irradiated and non-irradiated lesions as evidenced by PSA response, pain reduction, and/or tumour measurements.
A study in JNCI Cancer Spectrum has identified a connection between prolonged time spent sitting while watching TV and an increased risk of colorectal cancer for younger Americans.
